CD8A and neoplasm: To confirm, we tested the treatment combinations in mice pretreated with a CD8 depleting antibody, finding that the suppression of tumour growth in the IR+PI3Kγ inhibitor group is abrogated in the absence of CD8+ T cells (figure 7F).